Aktia Medica (AKTMEDA:FH)
was acquired by AKTAV:FH
Aktia Medica is an open-end fund registered in Finland. The Fund's objective is a long-term return that exceeds that of the Fund's benchmark, a composite made up of 80% MSCI World Pharma & Biotech, and 20% NASDAQ Biotech. The Fund invests in 75% in pharmaceutical companies, and 25% biotech companies. 60% of investments are in the USA, 32% in Europe, and 8% in Japan.